APA (7th ed.) Citation

de Bray, A., Schnitzer, H., Mahase, E., Singh, P., Andrews, R., McGowan, B. M., . . . Hazlehurst, J. M. (2026). Variation in the Commissioning of Semaglutide for the Treatment of Obesity and Overweight Across England: Results of Three Freedom of Information‐Based Mapping Exercises Across the 42 Integrated Care Boards of England. Clinical Obesity, 16(1), 1. https://doi.org/10.1111/cob.70044

Chicago Style (17th ed.) Citation

de Bray, Anne, et al. "Variation in the Commissioning of Semaglutide for the Treatment of Obesity and Overweight Across England: Results of Three Freedom of Information‐Based Mapping Exercises Across the 42 Integrated Care Boards of England." Clinical Obesity 16, no. 1 (2026): 1. https://doi.org/10.1111/cob.70044.

MLA (9th ed.) Citation

de Bray, Anne, et al. "Variation in the Commissioning of Semaglutide for the Treatment of Obesity and Overweight Across England: Results of Three Freedom of Information‐Based Mapping Exercises Across the 42 Integrated Care Boards of England." Clinical Obesity, vol. 16, no. 1, 2026, p. 1, https://doi.org/10.1111/cob.70044.